-
Professor Xin Yao: Precision Medicine and Minimally Invasive Technologies Working Together to Advance Urologic Oncology Care
With the rapid development of molecular imaging, artificial intelligence, multi-omics technologies, and robotic surgery, the management of urologic cancers is gradually evolving from relatively standardized treatment toward more precise, minimally invasive, and individualized whole-course care. Precision medicine can improve the accuracy of tumor identification, risk stratification, and treatment selection, while robotic-assisted surgery provides important technical…
-
Advancing Clinical Innovation and Shaping the Future of Urology — Professor Liqun Zhou on the Development of Clinical Research and the Training of Young Urologists
The Third Yellow River Urology Congress and the 31st Academic Conference of the Shandong Medical Association on Urology were recently held successfully. The conference brought together numerous experts and scholars in urology from across China to discuss cutting-edge advances, innovations in clinical practice, talent development, and regional collaboration. Oncology Frontier · UroStream invited Professor Liqun…
-
Professor Shaoxing Zhu: Achieving Deep Testosterone Suppression and Maximizing Patient Benefit — Individualized ADT-Based Treatment Strategies for Prostate Cancer
In recent years, the incidence and mortality of prostate cancer in China have increased significantly, driven by socioeconomic development and population aging, resulting in a growing disease burden. Androgen deprivation therapy (ADT), whether used alone or in combination, remains a cornerstone of comprehensive prostate cancer management. With updates to the Chinese Expert Consensus on Testosterone…
-
When All Seems Lost? — Rethinking the Optimal Treatment Sequence for Comprehensive Management of Advanced Renal Cell Carcinoma
With the advent of immune checkpoint inhibitors, advanced renal cell carcinoma (RCC) has gradually entered the “immunotherapy era.” Targeted therapy plus immunotherapy (IO+TKI) combinations are now recommended by major guidelines and have become part of the first-line treatment landscape for advanced RCC. Although head-to-head trials have unequivocally demonstrated the superiority of first-line IO+TKI combinations over…
-
Professor Shangqing Ren: Advancing Technological Innovation and Prioritizing Functional Preservation — Progress in Urologic Oncology and the Development of Young Physicians
In recent years, technologies, therapeutic agents, and treatment concepts in urologic oncology have continued to evolve, with precision, minimally invasive treatment, and functional preservation emerging as key directions for high-quality specialty development. From 5G-enabled remote robotic surgery expanding access to high-quality medical resources, to the continued advancement of systemic therapy for prostate cancer toward earlier…
-
Professor Mo Zhang: Fine Risk Stratification and Multimodal Integration — Exploring Precision Diagnosis and Treatment for High-Risk and Locally Advanced Prostate Cancer
High-risk and locally advanced prostate cancer is characterized by substantial biological heterogeneity, with significant differences in recurrence risk, metastatic potential, and treatment response among patients, making it a major challenge in clinical practice. With the development of novel androgen receptor pathway inhibitors, PSMA PET/CT, multi-omics technologies, and artificial intelligence, overcoming the limitations of traditional risk…
-
AIDS 2026 | Natalie Maricich: Balancing Algorithmic Capabilities and Human Empathy to Build a Sustainable Smart Health Service Model for HIV
At AIDS 2026, Sarah Morris, Chief Product Officer of Audere, delivered a presentation titled From Algorithms to Empathy: Artificial Intelligence in Self-Care Support for HIV Services, sharing cutting-edge practical experience and exploring the value and boundaries of AI technology deployed in long-term HIV health management. As AI gradually penetrates multiple self-care scenarios including medication adherence…
-
Professor Xiaojie Bian: Advances and Future Directions in the Treatment of Advanced Prostate Cancer in the Era of Precision Stratification
In recent years, the treatment paradigm for advanced prostate cancer has undergone a profound transformation, shifting from conventional empiric treatment toward precision stratification. With the increasing availability of genetic testing and the emergence of novel targeted therapies, individualized treatment based on molecular characteristics has become an important direction in clinical practice. Oncology Frontier · UroStream…
Connecting Medical Expertise through Media